Oramed Pharmaceuticals Inc (ORMP) insider trading
Every open-market stock purchase and sale by Oramed Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Arie Mayer (Director), $8.4K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ORMP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 30, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $1.4M |
| Mar 30, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $148K |
| Mar 17, 2026 | Avraham Gabay (CFO) | Bought (not open market) | — |
| Mar 17, 2026 | Joshua Hexter (COO) | Bought (not open market) | — |
| Mar 17, 2026 | Nadav Kidron (CEO) | Bought (not open market) | — |
| Mar 17, 2026 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Mar 12, 2026 | Nadav Kidron (CEO) | Sold (not open market) | — |
| Jan 22, 2026 | Avraham Gabay (CFO) | Bought (not open market) | — |
| Jan 22, 2026 | Joshua Hexter (COO) | Bought (not open market) | — |
| Jan 22, 2026 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Jan 22, 2026 | Nadav Kidron (CEO) | Bought (not open market) | — |
| Jan 14, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | — |
| Dec 31, 2025 | Avraham Gabay (CFO) | Bought (not open market) | — |
| Dec 31, 2025 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Nadav Kidron (CEO) | Bought (not open market) | — |
| Dec 31, 2025 | Arie Mayer (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Arie Mayer (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Yehuda Reznick (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Yehuda Reznick (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Benjamin Shapiro (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Benjamin Shapiro (Director) | Bought (not open market) | — |
| Dec 31, 2025 | Joshua Hexter (COO) | Bought (not open market) | — |
| Dec 31, 2025 | Joshua Hexter (COO) | Bought (not open market) | — |
Who's trading ORMP
- Miriam Kidron, C-suite exec: other filings, last Mar 30, 2026
- Nadav Kidron, CEO: other filings, last Mar 30, 2026
- Avraham Gabay, CFO: other filings, last Mar 17, 2026
- Joshua Hexter, COO: other filings, last Mar 17, 2026
- Daniel Aghion, Director: other filings, last Dec 31, 2025
- Arie Mayer, Director: other filings, last Dec 31, 2025
- Yehuda Reznick, Director: other filings, last Dec 31, 2025
- Benjamin Shapiro, Director: other filings, last Dec 31, 2025
Get free alerts when an insider at Oramed Pharmaceuticals Inc files a new trade →